Search

everythinglearnresearchcommunity

for

Search:↓

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Topical tofacitinib is effective and safe for treating alopecia areata.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Consider benefits and risks of new alopecia treatments for safety.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Nebivolol cream may be a promising hair loss treatment by improving blood flow and nourishing hair follicles.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.